Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

NYU Langone Health

Status: Completed

Conditions: Hypertension; Medication Adherence

Treatments: Behavioral: Health Information Technology (HIT) Platform; Behavioral: Peer Delivery of Medications

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05051124

20-01579

1R56HL150036 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overall objective of this project is to utilize the PRECEDE-PROCEED framework to conduct transdisciplinary, translational implementation research focused on improving medication adherence for hypertension control. The central hypothesis is that peer delivery of medications integrated with HIT (PT4A) will be effective in improving hypertension medication adherence, contributing to improved blood pressure among patients with uncontrolled hypertension in western Kenya. This study record will focus on Sub-Aim 2.2: a pilot of the intervention and a survey questionnaire with patients, peers, and clinical staff to evaluate feasibility. The investigators will evaluate impact on systolic blood pressure, medication adherence, and fidelity of implementation. The investigators will also create a retrospective comparator (control) group of CDM patients, through querying AMRS, matched by sex, age, location and initial blood pressure level. The investigators will then use their recorded blood pressure over a comparable period of up to 1 year and to allow for comparison to the blood pressure changes observed in the patients enrolled in the PT4A program to help understand the magnitude and variance of the intervention effects.

Enrollment: 101 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients ≥ 18 years old
• Enrolled in the AMPATH CDM PRogram
• Have uncontrolled hypertension (defined as systolic blood pressures ≥ 140 or diastolic blood pressure ≥ 90)

Exclusion criteria

• Acute illness requiring immediate medical attention
• Terminal illness
• Inability to provide informed consent

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

101 participants in 1 patient group

Patients Enrolled in the AMPATH CDM Program

Experimental group

Treatment:

Behavioral: Peer Delivery of Medications

Behavioral: Health Information Technology (HIT) Platform